Cross-protection data for Gardasil submitted to FDA.
D005260:Female; D005833:Genital Neoplasms, Female / Q000517:prevention & control; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D017387:Investigational New Drug Application; D053918:Papillomavirus Vaccines; D014481:United States
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines